← All trials
NCT05131295
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 5, 2007
- Primary completion
- Dec 7, 2008
- Completion date
- Mar 10, 2009
- First posted
- Nov 23, 2021
- Last posted
- Nov 23, 2021
- Enrollment
- 49
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco SuarezLead sponsor
- El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco SuarezOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.